LAB
Standard BioTools Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.69
+1.72%Margins
Gross margin
49.1%
EBITDA margin
-108.6%
EBIT margin
-94.8%
Net margin
-103.3%
FCF margin
-97.6%
-16.2%
Return on equity
-13.9%
Return on assets
-14.1%
Return on invested capital
0.13x
Asset turnover
-$80.3M
Cash from operations
$1.21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026